NCT03652077 2021-11-15A Safety and Tolerability Study of INCAGN02390 in Select Advanced MalignanciesIncyte CorporationPhase 1 Completed40 enrolled
NCT00003597 2014-07-24Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid TumorsChildren's Oncology GroupPhase 1 Completed16 enrolled
NCT00003022 2013-07-03Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal CancerMemorial Sloan Kettering Cancer CenterPhase 1 Completed
NCT00020579 2012-03-15MS-275 in Treating Patients With Advanced Solid Tumors or LymphomaNational Institutes of Health Clinical Center (CC)Phase 1 Completed75 enrolled